ID   TTC3_HUMAN              Reviewed;        2025 AA.
AC   P53804; A8K7H7; B2RPA7; D3DSG9; D3DSH2; D3DSH3; O60767; P78476;
AC   P78477; Q569I2; Q6P578; Q9UEK4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=E3 ubiquitin-protein ligase TTC3;
DE            EC=2.3.2.27;
DE   AltName: Full=Protein DCRR1;
DE   AltName: Full=RING finger protein 105;
DE   AltName: Full=RING-type E3 ubiquitin transferase TTC3 {ECO:0000305};
DE   AltName: Full=TPR repeat protein D;
DE   AltName: Full=Tetratricopeptide repeat protein 3;
DE            Short=TPR repeat protein 3;
GN   Name=TTC3; Synonyms=DCRR1, RNF105, TPRD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TPRDI), AND VARIANT HIS-1751.
RC   TISSUE=Brain;
RX   PubMed=8724848; DOI=10.1093/dnares/3.1.9;
RA   Ohira M., Ootsuyama A., Suzuki E., Ichikawa H., Seki N., Nagase T.,
RA   Nomura N., Ohki M.;
RT   "Identification of a novel human gene containing the tetratricopeptide
RT   repeat domain from the Down syndrome region of chromosome 21.";
RL   DNA Res. 3:9-16(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TPRDI; TPRDII AND TPRDIII), AND
RP   VARIANT HIS-1751.
RC   TISSUE=Fetal brain, and Placenta;
RX   PubMed=8947847; DOI=10.1093/oxfordjournals.jbchem.a021485;
RA   Tsukahara F., Hattori M., Muraki T., Sakaki Y.;
RT   "Identification and cloning of a novel cDNA belonging to
RT   tetratricopeptide repeat gene family from Down syndrome-critical
RT   region 21q22.2.";
RL   J. Biochem. 120:820-827(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM TPRDI).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-627 (ISOFORM TPRDI).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 85-2025 (ISOFORM TPRDI), AND VARIANT
RP   THR-840.
RX   PubMed=9254009; DOI=10.3109/10425179709034031;
RA   Eki T., Abe M., Naitou M., Sasanuma S.I., Nohata J., Kawashima K.,
RA   Ahmad I., Hanaoka F., Murakami Y.;
RT   "Cloning and characterization of novel gene, DCRR1, expressed from
RT   Down's syndrome critical region of human chromosome 21q22.2.";
RL   DNA Seq. 7:153-164(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 121-616 (ISOFORM TPRDI).
RC   TISSUE=Fetal brain;
RX   PubMed=9503011; DOI=10.1006/geno.1997.5146;
RA   Dahmane N., Ait-Ghezala G., Gosset P., Chamoun Z.,
RA   Dufresne-Zacharia M.-C., Lopes C., Rabatel N., Gassanova-Maugenre S.,
RA   Chettouh Z., Abramowski V., Fayet E., Yaspo M.-L., Korn B.,
RA   Blouin J.-L., Lehrach H., Poustka A., Antonarakis S.E., Sinet P.-M.,
RA   Creau N., Delabar J.-M.;
RT   "Transcriptional map of the 2.5-Mb CBR-ERG region of chromosome 21
RT   involved in Down syndrome.";
RL   Genomics 48:12-23(1998).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH CIT.
RX   PubMed=17488780; DOI=10.1242/jcs.000703;
RA   Berto G., Camera P., Fusco C., Imarisio S., Ambrogio C., Chiarle R.,
RA   Silengo L., Di Cunto F.;
RT   "The Down syndrome critical region protein TTC3 inhibits neuronal
RT   differentiation via RhoA and Citron kinase.";
RL   J. Cell Sci. 120:1859-1867(2007).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH AKT1; AKT2 AND AKT3,
RP   PHOSPHORYLATION AT SER-378, AND MUTAGENESIS OF SER-378.
RX   PubMed=20059950; DOI=10.1016/j.devcel.2009.09.007;
RA   Suizu F., Hiramuki Y., Okumura F., Matsuda M., Okumura A.J.,
RA   Hirata N., Narita M., Kohno T., Yokota J., Bohgaki M., Obuse C.,
RA   Hatakeyama S., Obata T., Noguchi M.;
RT   "The E3 ligase TTC3 facilitates ubiquitination and degradation of
RT   phosphorylated Akt.";
RL   Dev. Cell 17:800-810(2009).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-1289.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates the
CC       ubiquitination and subsequent degradation of phosphorylated Akt
CC       (AKT1, AKT2 and AKT3) in the nucleus. Acts as a terminal regulator
CC       of Akt signaling after activation; its phosphorylation by Akt,
CC       which is a prerequisite for ubiquitin ligase activity, suggests
CC       the existence of a regulation mechanism required to control Akt
CC       levels after activation. Catalyzes the formation of 'Lys-48'-
CC       polyubiquitin chains. May play a role in neuronal differentiation
CC       inhibition via its interaction with CIT.
CC       {ECO:0000269|PubMed:17488780, ECO:0000269|PubMed:20059950}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts (when phosphorylated on Ser-378) with AKT1,
CC       AKT2 and AKT3 (when phosphorylated). Interacts with CIT.
CC       {ECO:0000269|PubMed:17488780, ECO:0000269|PubMed:20059950}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20059950}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=TPRDI;
CC         IsoId=P53804-1; Sequence=Displayed;
CC       Name=TPRDII;
CC         IsoId=P53804-2; Sequence=VSP_006554;
CC       Name=TPRDIII;
CC         IsoId=P53804-3; Sequence=VSP_006555;
CC   -!- TISSUE SPECIFICITY: Found in all tissues examined.
CC   -!- PTM: Phosphorylation on Ser-378 by Akt is required for ubiquitin
CC       ligase activity. {ECO:0000269|PubMed:20059950}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63033.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH92466.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D83077; BAA11769.1; -; mRNA.
DR   EMBL; D84294; BAA12301.1; -; mRNA.
DR   EMBL; D84295; BAA12302.1; -; mRNA.
DR   EMBL; D84296; BAA12303.1; -; mRNA.
DR   EMBL; AP001429; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001432; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09716.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09717.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09718.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09719.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09720.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09721.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09722.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09723.1; -; Genomic_DNA.
DR   EMBL; BC063033; AAH63033.1; ALT_SEQ; mRNA.
DR   EMBL; BC092466; AAH92466.1; ALT_SEQ; mRNA.
DR   EMBL; BC137345; AAI37346.1; -; mRNA.
DR   EMBL; AK291992; BAF84681.1; -; mRNA.
DR   EMBL; D83327; BAA23666.1; -; mRNA.
DR   EMBL; AJ001866; CAA05057.1; -; mRNA.
DR   CCDS; CCDS13651.1; -. [P53804-1]
DR   PIR; JC5020; JC5020.
DR   RefSeq; NP_001001894.1; NM_001001894.2. [P53804-1]
DR   RefSeq; NP_001307633.1; NM_001320704.1.
DR   RefSeq; NP_001317610.1; NM_001330681.1. [P53804-3]
DR   RefSeq; NP_001317611.1; NM_001330682.1. [P53804-3]
DR   RefSeq; NP_001317612.1; NM_001330683.1. [P53804-1]
DR   RefSeq; NP_003307.3; NM_003316.3. [P53804-1]
DR   RefSeq; XP_011528042.1; XM_011529740.2. [P53804-2]
DR   UniGene; Hs.368214; -.
DR   ProteinModelPortal; P53804; -.
DR   BioGrid; 113118; 26.
DR   IntAct; P53804; 27.
DR   MINT; MINT-1181179; -.
DR   STRING; 9606.ENSP00000346791; -.
DR   iPTMnet; P53804; -.
DR   PhosphoSitePlus; P53804; -.
DR   BioMuta; TTC3; -.
DR   DMDM; 313104040; -.
DR   EPD; P53804; -.
DR   MaxQB; P53804; -.
DR   PaxDb; P53804; -.
DR   PeptideAtlas; P53804; -.
DR   PRIDE; P53804; -.
DR   Ensembl; ENST00000354749; ENSP00000346791; ENSG00000182670. [P53804-1]
DR   Ensembl; ENST00000355666; ENSP00000347889; ENSG00000182670. [P53804-1]
DR   Ensembl; ENST00000399017; ENSP00000381981; ENSG00000182670. [P53804-1]
DR   GeneID; 7267; -.
DR   KEGG; hsa:7267; -.
DR   UCSC; uc002yvz.4; human. [P53804-1]
DR   CTD; 7267; -.
DR   DisGeNET; 7267; -.
DR   GeneCards; TTC3; -.
DR   H-InvDB; HIX0027791; -.
DR   H-InvDB; HIX0041033; -.
DR   H-InvDB; HIX0148527; -.
DR   HGNC; HGNC:12393; TTC3.
DR   HPA; HPA016810; -.
DR   HPA; HPA023964; -.
DR   HPA; HPA036304; -.
DR   MIM; 602259; gene.
DR   neXtProt; NX_P53804; -.
DR   OpenTargets; ENSG00000182670; -.
DR   PharmGKB; PA37058; -.
DR   eggNOG; ENOG410JR26; Eukaryota.
DR   eggNOG; ENOG41103HK; LUCA.
DR   GeneTree; ENSGT00530000063254; -.
DR   HOVERGEN; HBG007494; -.
DR   InParanoid; P53804; -.
DR   KO; K15712; -.
DR   OMA; SCQFLDD; -.
DR   OrthoDB; EOG091G00EM; -.
DR   PhylomeDB; P53804; -.
DR   TreeFam; TF333981; -.
DR   SIGNOR; P53804; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; TTC3; human.
DR   GeneWiki; TTC3; -.
DR   GenomeRNAi; 7267; -.
DR   PRO; PR:P53804; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000182670; -.
DR   CleanEx; HS_TTC3; -.
DR   ExpressionAtlas; P53804; baseline and differential.
DR   Genevisible; P53804; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 1.25.40.10; -; 2.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom.
DR   InterPro; IPR019734; TPR_repeat.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00028; TPR; 4.
DR   SUPFAM; SSF48452; SSF48452; 2.
DR   PROSITE; PS50005; TPR; 2.
DR   PROSITE; PS50293; TPR_REGION; 2.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; TPR repeat;
KW   Transferase; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   2025       E3 ubiquitin-protein ligase TTC3.
FT                                /FTId=PRO_0000106378.
FT   REPEAT      231    264       TPR 1.
FT   REPEAT      266    298       TPR 2.
FT   REPEAT      536    572       TPR 3.
FT   REPEAT      576    609       TPR 4.
FT   ZN_FING    1957   1997       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COMPBIAS    453    456       Poly-Ser.
FT   COMPBIAS   1018   1029       Arg/Lys-rich (basic).
FT   COMPBIAS   1020   1029       Poly-Lys.
FT   COMPBIAS   1172   1185       Arg/Lys-rich (basic).
FT   COMPBIAS   1563   1579       Arg/Lys-rich (basic).
FT   COMPBIAS   1899   1902       Poly-Lys.
FT   MOD_RES     378    378       Phosphoserine; by PKB/AKT2.
FT                                {ECO:0000269|PubMed:20059950}.
FT   MOD_RES    1009   1009       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88196}.
FT   MOD_RES    1061   1061       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88196}.
FT   VAR_SEQ       1    310       Missing (in isoform TPRDIII).
FT                                {ECO:0000303|PubMed:8947847}.
FT                                /FTId=VSP_006555.
FT   VAR_SEQ       1    233       Missing (in isoform TPRDII).
FT                                {ECO:0000303|PubMed:8947847}.
FT                                /FTId=VSP_006554.
FT   VARIANT     840    840       M -> T (in dbSNP:rs1053808).
FT                                {ECO:0000269|PubMed:9254009}.
FT                                /FTId=VAR_020312.
FT   VARIANT    1154   1154       P -> S (in dbSNP:rs1053840).
FT                                /FTId=VAR_044428.
FT   VARIANT    1289   1289       K -> M (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035868.
FT   VARIANT    1751   1751       D -> H (in dbSNP:rs1053966).
FT                                {ECO:0000269|PubMed:8724848,
FT                                ECO:0000269|PubMed:8947847}.
FT                                /FTId=VAR_024676.
FT   MUTAGEN     378    378       S->A: Abolishes phosphorylation by Akt
FT                                and impairs ubiquitin ligase activity on
FT                                Akt. {ECO:0000269|PubMed:20059950}.
FT   CONFLICT      9      9       F -> Y (in Ref. 5; AAH92466).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       N -> D (in Ref. 8; CAA05057).
FT                                {ECO:0000305}.
FT   CONFLICT    139    139       K -> R (in Ref. 8; CAA05057).
FT                                {ECO:0000305}.
FT   CONFLICT    232    232       E -> G (in Ref. 8; CAA05057).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       L -> P (in Ref. 8; CAA05057).
FT                                {ECO:0000305}.
FT   CONFLICT    437    437       K -> Q (in Ref. 5; AAH63033).
FT                                {ECO:0000305}.
FT   CONFLICT    495    495       Q -> P (in Ref. 7; BAA23666).
FT                                {ECO:0000305}.
FT   CONFLICT   1700   1700       E -> V (in Ref. 7; BAA23666).
FT                                {ECO:0000305}.
FT   CONFLICT   1822   1822       A -> T (in Ref. 7; BAA23666).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2025 AA;  229869 MW;  C80BC8E1970B6725 CRC64;
     MDNFAEGDFT VADYALLEDC PHVDDCVFAA EFMSNDYVRV TQLYCDGVGV QYKDYIQSER
     NLEFDICSIW CSKPISVLQD YCDAIKINIF WPLLFQHQNS SVISRLHPCV DANNSRASEI
     NLKKLQHLEL MEDIVDLAKK VANDSFLIGG LLRIGCKIEN KILAMEEALN WIKYAGDVTI
     LTKLGSIDNC WPMLSIFFTE YKYHITKIVM EDCNLLEELK TQSCMDCIEE GELMKMKGNE
     EFSKERFDIA IIYYTRAIEY RPENYLLYGN RALCFLRTGQ FRNALGDGKR ATILKNTWPK
     GHYRYCDALS MLGEYDWALQ ANIKAQKLCK NDPEGIKDLI QQHVKLQKQI EDLQGRTANK
     DPIKAFYENR AYTPRSLSAP IFTTSLNFVE KERDFRKINH EMANGGNQNL KVADEALKVD
     DCDCHPEFSP PSSQPPKHKG KQKSRNNESE KFSSSSPLTL PADLKNILEK QFSKSSRAAH
     QDFANIMKML RSLIQDGYMA LLEQRCRSAA QAFTELLNGL DPQKIKQLNL AMINYVLVVY
     GLAISLLGIG QPEELSEAEN QFKRIIEHYP SEGLDCLAYC GIGKVYLKKN RFLEALNHFE
     KARTLIYRLP GVLTWPTSNV IIEESQPQKI KMLLEKFVEE CKFPPVPDAI CCYQKCHGYS
     KIQIYITDPD FKGFIRISCC QYCKIEFHMN CWKKLKTTTF NDKIDKDFLQ GICLTPDCEG
     VISKIIIFSS GGEVKCEFEH KVIKEKVPPR PILKQKCSSL EKLRLKEDKK LKRKIQKKEA
     KKLAQERMEE DLRESNPPKN EEQKETVDNV QRCQFLDDRI LQCIKQYADK IKSGIQNTAM
     LLKELLSWKV LSTEDYTTCF SSRNFLNEAV DYVIRHLIQE NNRVKTRIFL HVLSELKEVE
     PKLAAWIQKL NSFGLDATGT FFSRYGASLK LLDFSIMTFL WNEKYGHKLD SIEGKQLDYF
     SEPASLKEAR CLIWLLEEHR DKFPALHSAL DEFFDIMDSR CTVLRKQDSG EAPFSSTKVK
     NKSKKKKPKD SKPMLVGSGT TSVTSNNEII TSSEDHSNRN SDSAGPFAVP DHLRQDVEEF
     EALYDQHSNE YVVRNKKLWD MNPKQKCSTL YDYFSQFLEE HGPLDMSNKM FSAEYEFFPE
     ETRQILEKAG GLKPFLLGCP RFVVIDNCIA LKKVASRLKK KRKKKNIKTK VEEISKAGEY
     VRVKLQLNPA AREFKPDVKS KPVSDSSSAP AFENVKPKPV SANSPKPACE DVKAKPVSDN
     SSRQVSEDGQ PKGVSSNSPK PGSEDANYKR VSCNSPKPVL EDVKPTYWAQ SHLVTGYCTY
     LPFQRFDITQ TPPAYINVLP GLPQYTSIYT PLASLSPEYQ LPRSVPVVPS FVANDRADKN
     AAAYFEGHHL NAENVAGHQI ASETQILEGS LGISVKSHCS TGDAHTVLSE SNRNDEHCGN
     SNNKCEVIPE STSAVTNIPH VQMVAIQVSW NIIHQEVNTE PYNPFEERQG EISRIEKEHQ
     VLQDQLQEVY ENYEQIKLKG LEETRDLEEK LKRHLEENKI SKTELDWFLQ DLEREIKKWQ
     QEKKEIQERL KSLKKKIKKV SNASEMYTQK NDGKEKEHEL HLDQSLEISN TLTNEKMKIE
     EYIKKGKEDY EESHQRAVAA EVSVLENWKE SEVYKLQIME SQAEAFLKKL GLISRDPAAY
     PDMESDIRSW ELFLSNVTKE IEKAKSQFEE QIKAIKNGSR LSELSKVQIS ELSFPACNTV
     HPELLPESSG DDGQGLVTSA SDVTGNHAAL HRDPSVFSAG DSPGEAPSAL LPGPPPGQPE
     ATQLTGPKRA GQAALSERSP VADRKQPVPP GRAARSSQSP KKPFNSIIEH LSVVFPCYNS
     TELAGFIKKV RSKNKNSLSG LSIDEIVQRV TEHILDEQKK KKPNPGKDKR TYEPSSATPV
     TRSSQGSPSV VVAPSPKTKG QKAEDVPVRI ALGASSCEIC HEVFKSKNVR VLKCGHKYHK
     GCFKQWLKGQ SACPACQGRD LLTEESPSGR GWPSQNQELP SCSSR
//
